1. Verma, Megha, Schneider, Jay S. 2019. siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegeneration. In Molecular and cellular neurosciences, 95, 25-30. doi:10.1016/j.mcn.2019.01.001. https://pubmed.ncbi.nlm.nih.gov/30611881/
2. Sha, Yongliang, Zhuang, Huijie, Shi, Jin, Guo, Hao, Cheng, Hui. 2024. B3GALT4 modulates tumor progression and autophagy by AKT/mTOR signaling pathway in breast cancer. In Discover oncology, 15, 488. doi:10.1007/s12672-024-01371-9. https://pubmed.ncbi.nlm.nih.gov/39331217/
3. Zhang, Ting, Wang, Fang, Wu, Jing-Yi, Mao, Yong, Hua, Dong. . Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. In World journal of gastroenterology, 24, 3538-3546. doi:10.3748/wjg.v24.i31.3538. https://pubmed.ncbi.nlm.nih.gov/30131660/
4. Madrid, Andy, Hogan, Kirk J, Papale, Ligia A, Johnson, Sterling C, Alisch, Reid S. . DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease. In Journal of Alzheimer's disease : JAD, 66, 927-934. doi:10.3233/JAD-180592. https://pubmed.ncbi.nlm.nih.gov/30372681/